Fig. 2From: Comorbidities and co-medications in populations with and without chronic hepatitis C virus infection in Japan between 2015 and 2016Prevalence of systemic diseases by age group in chronic HCV patients and non-HCV patients. a diseases of oesophagus, stomach and duodenum; b hypertensive diseases; c metabolic disorders; d diabetes mellitus; e psychiatric disorders; f neoplasms other than liver cancers; g cardiovascular diseases; h dermatitis and eczema; i liver cancers; and j renal failureBack to article page